Liposome formulation effective in the treatment of hypertension

WO2026117220A1PCT designated stage Publication Date: 2026-06-04ANADOLU UNIVERSITESI STRATEJI GELISTIRME DAIRESI BASKANLIGI
View PDF 0 Cites 0 Cited by

Patent Information

Authority / Receiving Office
WO · WO
Patent Type
Applications
Current Assignee / Owner
ANADOLU UNIVERSITESI STRATEJI GELISTIRME DAIRESI BASKANLIGI
Filing Date
2025-11-28
Publication Date
2026-06-04

Smart Images

  • Figure 00000008_0000
    Figure 00000008_0000
  • Figure 00000009_0000
    Figure 00000009_0000
  • Figure 00000010_0000
    Figure 00000010_0000
Patent Text Reader

Abstract

The invention relates to a medicine formed with liposomes, which are lipid-based nano drug carrier systems containing nadolol as the active substance, for use in the treatment of hypertension, and to the production method of this product. With the said nano formulation, a medicine having high bioavailability and compliance values is obtained.
Need to check novelty before this filing date? Find Prior Art